Company Filing History:
Years Active: 2025
Title: Henricus Egbertus Gerardus Van Erp: Innovator in Triacylglycerol Production
Introduction
Henricus Egbertus Gerardus Van Erp is a notable inventor based in Harpenden, GB. He has made significant contributions to the field of biotechnology, particularly in the production of triacylglycerol through genetically modified organisms. His innovative work has implications for various applications, including infant formula.
Latest Patents
Henricus Van Erp holds a patent for a non-human organism designed for producing triacylglycerol. This patent describes non-human organisms that are genetically modified to express a lysophosphatidic acid acyltransferase specific for C16:0-Coenzyme A (C16:0 LPAT). The C16:0 LPAT is localized in the endoplasmic reticulum, enhancing the organism's ability to produce triacylglycerol. The patent also outlines methods for extracting triacylglycerol from these organisms, which can be utilized in infant formula.
Career Highlights
Henricus Van Erp is associated with Rothamsted Research Limited, where he has been involved in groundbreaking research. His work focuses on the genetic modification of organisms to improve the production of valuable compounds like triacylglycerol. His innovative approaches have positioned him as a key figure in the field of agricultural biotechnology.
Collaborations
Henricus has collaborated with notable colleagues such as Peter Eastmond and Govindprasad Bhutada. These collaborations have furthered research efforts and contributed to advancements in the field.
Conclusion
Henricus Egbertus Gerardus Van Erp is a pioneering inventor whose work in genetically modified organisms for triacylglycerol production has significant implications for biotechnology and infant nutrition. His contributions continue to influence the field and inspire future innovations.